{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "P",
          "position": "30"
        },
        "variant_string_id": "SNCA A30P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "a-Syn is implicated in PD through its role in membrane binding and synaptogenesis.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines a-Syn's role in PD."
        },
        {
          "step_name": "Step 2: Evaluate applicability of assay",
          "extracted_paper_info": "Assay measures membrane binding, key to a-Syn's function.",
          "judgment": "Yes",
          "reasoning": "The assay directly relates to the disease mechanism."
        },
        {
          "step_name": "Step 3a: Controls and Replicates",
          "extracted_paper_info": "Wild-type controls used with replicates in assays.",
          "judgment": "Yes",
          "reasoning": "Controls and replicates are adequately addressed."
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "A53T acts as control showing normal binding.",
          "judgment": "Yes",
          "reasoning": "Variant controls support the assessment."
        },
        {
          "step_name": "Step 4b: Number ofControls",
          "extracted_paper_info": "Multiple controls used across variants.",
          "judgment": "At least 11 in total",
          "reasoning": "Supports moderate strength evidence."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "A30P shows impaired membrane binding, supporting a pathogenic role with moderate evidence."
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "T",
          "position": "53"
        },
        "variant_string_id": "SNCA A53T"
      },
      "functional_evidence_aim": "Benign",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "a-Syn is implicated in PD through its role in membrane binding and synaptogenesis.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines a-Syn's role in PD."
        },
        {
          "step_name": "Step 2: Evaluate applicability of assay",
          "extracted_paper_info": "Assay measures membrane binding, key to a-Syn's function.",
          "judgment": "Yes",
          "reasoning": "The assay directly relates to the disease mechanism."
        },
        {
          "step_name": "Step 3a: Controls and Replicates",
          "extracted_paper_info": "Wild-type controls used with replicates in assays.",
          "judgment": "Yes",
          "reasoning": "Controls and replicates are adequately addressed."
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "A53T compared against WT showing normal binding.",
          "judgment": "Yes",
          "reasoning": "Variant controls support the assessment."
        },
        {
          "step_name": "Step 4b: Number ofControls",
          "extracted_paper_info": "Multiple controls used across variants.",
          "judgment": "At least 11 in total",
          "reasoning": "Supports moderate strength evidence."
        }
      ],
      "final_evidence_strength": {
        "type": "Benign",
        "strength": "BS3_moderate"
      },
      "overall_conclusion": "A53T shows normal membrane binding, supporting a benign role with moderate evidence."
    }
  ]
}